FDA Approved: ARMODAFINIL — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for ARMODAFINIL submitted by Mylan Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy
• Obstructive Sleep Apnea
• Shift Work Sleep Disorder

Drugs mentioned

• Armodafinil (armodafinil)

Snippet

SUPPL AP for ARMODAFINIL (ARMODAFINIL)